1. Home
  2. GDST vs KZR Comparison

GDST vs KZR Comparison

Compare GDST & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDST
  • KZR
  • Stock Information
  • Founded
  • GDST 2020
  • KZR 2015
  • Country
  • GDST United States
  • KZR United States
  • Employees
  • GDST N/A
  • KZR N/A
  • Industry
  • GDST
  • KZR Biotechnology: Pharmaceutical Preparations
  • Sector
  • GDST
  • KZR Health Care
  • Exchange
  • GDST NYSE
  • KZR Nasdaq
  • Market Cap
  • GDST 39.5M
  • KZR 43.0M
  • IPO Year
  • GDST 2022
  • KZR 2018
  • Fundamental
  • Price
  • GDST $11.48
  • KZR $6.05
  • Analyst Decision
  • GDST
  • KZR Hold
  • Analyst Count
  • GDST 0
  • KZR 2
  • Target Price
  • GDST N/A
  • KZR $9.00
  • AVG Volume (30 Days)
  • GDST 2.6K
  • KZR 26.2K
  • Earning Date
  • GDST 01-01-0001
  • KZR 03-13-2025
  • Dividend Yield
  • GDST N/A
  • KZR N/A
  • EPS Growth
  • GDST N/A
  • KZR N/A
  • EPS
  • GDST 0.16
  • KZR N/A
  • Revenue
  • GDST N/A
  • KZR N/A
  • Revenue This Year
  • GDST N/A
  • KZR N/A
  • Revenue Next Year
  • GDST N/A
  • KZR N/A
  • P/E Ratio
  • GDST $73.15
  • KZR N/A
  • Revenue Growth
  • GDST N/A
  • KZR N/A
  • 52 Week Low
  • GDST $10.90
  • KZR $5.20
  • 52 Week High
  • GDST $12.45
  • KZR $11.40
  • Technical
  • Relative Strength Index (RSI)
  • GDST 48.88
  • KZR 43.79
  • Support Level
  • GDST $11.50
  • KZR $5.86
  • Resistance Level
  • GDST $12.41
  • KZR $6.57
  • Average True Range (ATR)
  • GDST 0.14
  • KZR 0.27
  • MACD
  • GDST -0.03
  • KZR 0.02
  • Stochastic Oscillator
  • GDST 2.11
  • KZR 25.97

About GDST GOLDENSTONE ACQUISITION LIMITED

Goldenstone Acquisition Ltd is a newly organized blank check company. It is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

About KZR Kezar Life Sciences Inc.

Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.

Share on Social Networks: